You are here » Home » Companies » Company Overview » Combat Drugs Ltd

Combat Drugs Ltd.

BSE: 524752 Sector: Health care
NSE: N.A. ISIN Code: INE643N01012
BSE LIVE 11:50 | 26 Apr 10.80 0.51
(4.96%)
OPEN

10.80

HIGH

10.80

LOW

10.80

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 10.80
PREVIOUS CLOSE 10.29
VOLUME 2090
52-Week high 11.71
52-Week low 3.49
P/E
Mkt Cap.(Rs cr) 8.64
Buy Price 10.80
Buy Qty 144410.00
Sell Price 0.00
Sell Qty 0.00
OPEN 10.80
CLOSE 10.29
VOLUME 2090
52-Week high 11.71
52-Week low 3.49
P/E
Mkt Cap.(Rs cr) 8.64
Buy Price 10.80
Buy Qty 144410.00
Sell Price 0.00
Sell Qty 0.00

Combat Drugs Ltd. (COMBATDRUGS) - Company History

Incorporated as a private limited company in Sep.'86, Combat Drugs (CDL) was converted into a public limited company in Jun.'92. The company was promoted by Suchit Mohan Lal and Ajay Karan. CDL came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.'94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables. CDL started commercial production in Jul.'87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar, Hyderabad, on lease from Fairchild Laboratories and commenced commercial production in Aug.'88. In Jul.'92 the manufacturing activities were shifted to the present leased premises at Kushaiguda, Hyderabad. In this unit various pharmaceutical formulations such as tablets, capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs, antibiotic drugs, anti-inflammatory drugs, haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96, the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational. During 1996-97, the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product "HB 2" has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate. During the year 1998-99, the Company initiated steps to diversify into information technology. The Company is in the process of taking over the business of M/s. Softech Institute of Information Technology & Software Development, which would function as the Infotech Division of the Company. The Company also proposes to change its name to "Combat Drugs and Softech Limited" so as to justify both the activities of Pharmaceutical Formulations and Information Technology.